Verzenio tablets 50mg

Verzenio (abemaciclib) tablets, 50mg (YJ code: 4291054F1026, standard: 50mg 1 tablet), manufactured by Eli Lilly Japan, are a CDK4/6 inhibitor used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, including early-stage, advanced, or metastatic disease. It works by interfering with proteins that control cancer cell division and growth.